Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2019

Open Access 01-12-2019 | Prednisolone | Research article

An application of a pattern-mixture model with multiple imputation for the analysis of longitudinal trials with protocol deviations

Authors: Abdul-Karim Iddrisu, Freedom Gumedze

Published in: BMC Medical Research Methodology | Issue 1/2019

Login to get access

Abstract

Background

The benefit of a given treatment can be evaluated via a randomized clinical trial design. However, protocol deviations may severely compromise treatment effect since such deviations often lead to missing values. The assumption that methods of analysis can account for the missing data cannot be justified and hence methods of analysis based on plausible assumptions should be used. An alternative analysis to the simple imputation methods requires unverifiable assumptions about the missing data. Therefore sensitivity analysis should be performed to investigate the robustness of statistical inferences to alternative assumptions about the missing data.

Aims

In this paper, we investigate the effect of tuberculosis pericarditis treatment (prednisolone) on CD4 count changes over time and draw inferences in the presence of missing data. The data come from a multicentre clinical trial (the IMPI trial).

Methods

We investigate the effect of prednisolone on CD4 count changes by adjusting for baseline and time-dependent covariates in the fitted model. To draw inferences in the presence of missing data, we investigate sensitivity of statistical inferences to missing data assumptions using the pattern-mixture model with multiple imputation (PM-MI) approach. We also performed simulation experiment to evaluate the performance of the imputation approaches.

Results

Our results showed that the prednisolone treatment has no significant effect on CD4 count changes over time and that the prednisolone treatment does not interact with time and anti-retroviral therapy (ART). Also, patients’ CD4 count levels significantly increase over the study period and patients on ART treatment have higher CD4 count levels compared with those not on ART. The results also showed that older patients had lower CD4 count levels compared with younger patients, and parameter estimates under the MAR assumption are robust to NMAR assumptions.

Conclusions

Since the parameter estimates under the MAR analysis are robust to NMAR analyses, the process that generated the missing data in the CD4 count measurements is missing at random (MAR). The implication is that valid inferences can be obtained using either the likelihood-based methods or multiple imputation approaches.
Literature
1.
go back to reference Carpenter JR, Roger JH, Kenward MG. Analysis of longitudinal trials with protocol deviation: A framework for relevant, accessible assumptions, and inference via multiple imputation. Biopharm Stat. 2013; 23(6):1352–71.CrossRef Carpenter JR, Roger JH, Kenward MG. Analysis of longitudinal trials with protocol deviation: A framework for relevant, accessible assumptions, and inference via multiple imputation. Biopharm Stat. 2013; 23(6):1352–71.CrossRef
2.
go back to reference Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996; 52(4):1324–33.CrossRef Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996; 52(4):1324–33.CrossRef
3.
go back to reference Council NR. The Prevention and Treatment of Missing Data in Clinical Trials, Panel on Handling Missing Data in Clinical Trials, Committee on National Statistics, Division of Behavioral and Social Sciences and Education.2010. Council NR. The Prevention and Treatment of Missing Data in Clinical Trials, Panel on Handling Missing Data in Clinical Trials, Committee on National Statistics, Division of Behavioral and Social Sciences and Education.2010.
4.
go back to reference Committee for medicinal products for human use (chmp) guideline on the choice of the non-inferiority margin. Stat Med. 2006; 25(10):1628. Committee for medicinal products for human use (chmp) guideline on the choice of the non-inferiority margin. Stat Med. 2006; 25(10):1628.
5.
go back to reference Little RJ, D’agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012; 367(14):1355–60.CrossRef Little RJ, D’agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012; 367(14):1355–60.CrossRef
6.
go back to reference O’neill R, Temple R. The prevention and treatment of missing data in clinical trials: an fda perspective on the importance of dealing with it. Clin Pharmacol Ther. 2012; 91(3):550–4.CrossRef O’neill R, Temple R. The prevention and treatment of missing data in clinical trials: an fda perspective on the importance of dealing with it. Clin Pharmacol Ther. 2012; 91(3):550–4.CrossRef
8.
9.
go back to reference Diggle P, Kenward MG. Informative drop-out in longitudinal data analysis. Appl Stat. 1994; 43(1):49–93.CrossRef Diggle P, Kenward MG. Informative drop-out in longitudinal data analysis. Appl Stat. 1994; 43(1):49–93.CrossRef
10.
go back to reference Wu MC, Carroll RJ. Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process. Biometrics. 1988; 44(1):175–88.CrossRef Wu MC, Carroll RJ. Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process. Biometrics. 1988; 44(1):175–88.CrossRef
11.
go back to reference Creemers A, Hens N, Aerts M, Molenberghs G, Verbeke G, Kenward MG. Generalized shared-parameter models and missingness at random. Stat Model. 2011; 11(4):279–310.CrossRef Creemers A, Hens N, Aerts M, Molenberghs G, Verbeke G, Kenward MG. Generalized shared-parameter models and missingness at random. Stat Model. 2011; 11(4):279–310.CrossRef
12.
go back to reference Yuan Y, Little RJ. Mixed-effect hybrid models for longitudinal data with nonignorable dropout. Biometrics. 2009; 65(2):478–86.CrossRef Yuan Y, Little RJ. Mixed-effect hybrid models for longitudinal data with nonignorable dropout. Biometrics. 2009; 65(2):478–86.CrossRef
13.
go back to reference Ratitch B, O’Kelly M, Tosiello R. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharm Stat. 2013; 12(6):337–47.CrossRef Ratitch B, O’Kelly M, Tosiello R. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models. Pharm Stat. 2013; 12(6):337–47.CrossRef
14.
go back to reference Mallinckrodt C, Roger J, Chuang-Stein C, Molenberghs G, O’Kelly M, Ratitch B, Janssens M, Bunouf P. Recent developments in the prevention and treatment of missing data. Therapeutic Innovation ands Regulatory Science. 2013. Mallinckrodt C, Roger J, Chuang-Stein C, Molenberghs G, O’Kelly M, Ratitch B, Janssens M, Bunouf P. Recent developments in the prevention and treatment of missing data. Therapeutic Innovation ands Regulatory Science. 2013.
15.
go back to reference Permutt T. Sensitivity analysis for missing data in regulatory submissions. Stat Med. 2016; 35(17):2876–9.CrossRef Permutt T. Sensitivity analysis for missing data in regulatory submissions. Stat Med. 2016; 35(17):2876–9.CrossRef
16.
go back to reference Little RJ, Rubin DB. Statistical analysis with missing data. Wiley. 2014. Little RJ, Rubin DB. Statistical analysis with missing data. Wiley. 2014.
17.
go back to reference Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996; 91(434):473–89.CrossRef Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996; 91(434):473–89.CrossRef
18.
go back to reference Mayosi BM, Ntsekhe M, Bosch J, Pogue J, Gumedze F, Badri M, Jung H, Pandie S, Smieja M, Thabane L, et al. Rationale and design of the investigation of the management of pericarditis (impi) trial: A 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and mycobacterium w immunotherapy in tuberculous pericarditis. Heart J. 2012; 165:109–15. Mayosi BM, Ntsekhe M, Bosch J, Pogue J, Gumedze F, Badri M, Jung H, Pandie S, Smieja M, Thabane L, et al. Rationale and design of the investigation of the management of pericarditis (impi) trial: A 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and mycobacterium w immunotherapy in tuberculous pericarditis. Heart J. 2012; 165:109–15.
19.
go back to reference Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, et al.Prednisolone and mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014. Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, et al.Prednisolone and mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014.
20.
go back to reference Rubin DB. The calculation of posterior distributions by data augmentation: Comment: A noniterative sampling/importance resampling alternative to the data augmentation algorithm for creating a few imputations when fractions of missing information are modest: The sir algorithm. J Am Stat Assoc. 1987; 82(398):543–6. Rubin DB. The calculation of posterior distributions by data augmentation: Comment: A noniterative sampling/importance resampling alternative to the data augmentation algorithm for creating a few imputations when fractions of missing information are modest: The sir algorithm. J Am Stat Assoc. 1987; 82(398):543–6.
21.
go back to reference Heckman JJ. The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models. Natl Bur Econ Res. 1976; 5(4):475–92. Heckman JJ. The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models. Natl Bur Econ Res. 1976; 5(4):475–92.
22.
go back to reference Wu MC, Bailey K. Analysing changes in the presence of informative right censoring caused by death and withdrawal. Stat Med. 1988; 7(1-2):337–46.CrossRef Wu MC, Bailey K. Analysing changes in the presence of informative right censoring caused by death and withdrawal. Stat Med. 1988; 7(1-2):337–46.CrossRef
23.
go back to reference Wu MC, Bailey KR. Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics. 1989; 45(3):939–55.CrossRef Wu MC, Bailey KR. Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics. 1989; 45(3):939–55.CrossRef
24.
go back to reference Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982; 38(4):963–74.CrossRef Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982; 38(4):963–74.CrossRef
25.
go back to reference Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the em algorithm. J R Stat Soc Ser B. 1977; 39(1):1–38. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the em algorithm. J R Stat Soc Ser B. 1977; 39(1):1–38.
26.
go back to reference Rubin DB. Formalizing subjective notions about the effect of nonrespondents in sample surveys. J Am Stat Assoc. 1977; 72(359):538–43.CrossRef Rubin DB. Formalizing subjective notions about the effect of nonrespondents in sample surveys. J Am Stat Assoc. 1977; 72(359):538–43.CrossRef
27.
go back to reference Molenberghs G, Beunckens C, Sotto C, Kenward MG. Every missingness not at random model has a missingness at random counterpart with equal fit. J R Stat Soc Ser B. 2008; 70(2):371–88.CrossRef Molenberghs G, Beunckens C, Sotto C, Kenward MG. Every missingness not at random model has a missingness at random counterpart with equal fit. J R Stat Soc Ser B. 2008; 70(2):371–88.CrossRef
28.
go back to reference Royston P. Multiple imputation of missing values: update of ice. Stata J. 2005; 5(4):527.CrossRef Royston P. Multiple imputation of missing values: update of ice. Stata J. 2005; 5(4):527.CrossRef
Metadata
Title
An application of a pattern-mixture model with multiple imputation for the analysis of longitudinal trials with protocol deviations
Authors
Abdul-Karim Iddrisu
Freedom Gumedze
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Prednisolone
Published in
BMC Medical Research Methodology / Issue 1/2019
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-018-0639-y

Other articles of this Issue 1/2019

BMC Medical Research Methodology 1/2019 Go to the issue